Safety considerations in contrast medium administration in radiological examination process

Chinese Journal of Radiology

Volumn 33, Issue 2, 2008, Pages 85-90

  Hsieh, Ming Chih ^a   Chen, Clayton Chi Chang ^b   Lee, Rheun Chuan ^c   Chan, Wing P ^a,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CONTRAST MEDIUM; CREATININE; GADOLINIUM; IODINATED CONTRAST MEDIUM; LOOP DIURETIC AGENT; MANNITOL; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT;

CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTRAST MEDIUM EXTRAVASATION; DRUG HYPERSENSITIVITY; HUMAN; LACTIC ACIDOSIS; NEPHROGENIC FIBROSING DERMOPATHY; NEPHROGENIC SYSTEMIC FIBROSIS; NEPHROTOXICITY; PATIENT SAFETY; RADIODIAGNOSIS; RADIOLOGY DEPARTMENT; RISK REDUCTION;

EID: 48249096002     PISSN: 10188940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Grainger RG. Intravascular contrast media. In: Grainger RG, Allison D, eds. Grainger and allison' s diagnostic radiology: a textbook of medical imaging. New york: Churchill livingstone, 1997: 40-41
2. Morcos SK, Thomsen HS, Webb JAW, and members of Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999; 9: 1602-1613
3. Thomsen HS, and Morcos SK. Radiographic contrast media. BJU International, 2000; 86: 1-10
4. Thomsen HS. Contrast nephropathy. In: Thomsen HS, Muller RN, Mattrey RF, eds. Trends in Contrast Media. Berlin: Springer Verlag, 1999: 103-116
5. Thomsen HS, Morcos SK, and the ESUR Contrast Media Safety Committee. Contrast media and metformin. Guidelines to diminish the risk of lactic acidosis in noninsulin dependent diabetics after administration of contrast media. Eur Radiol 1999; 9: 738-740
6. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and non-ionic contrast media. Radiology 1990; 175: 621-628
7. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjelllin I, and Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned. AJR Am J Roentgenol 2007; 188: 586-592
8. Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, and Garrett RW. Nephrogenic systemic fibrosis: Rise factors and incidence estimation. Radiology 2007; 243: 148-157
9. Burd DAR, Santis C, Milward TM. Severe extravasation injury: an avoidable iatrogenic disaster. Br Med J 1985; 290: 1579-1580
10. Cohan RH, Ellis JH, and Garner WL. Extravasation of radiographic contrast material: Recognition, prevention and treatment. Radiology 1996; 200: 593-604
11. Cohan RH, Leder RA, Bolick D, et al. Extravascular extravasation of radiographic contrast media: effects of conventional and low-osmolar agents in the rat thigh. Invest Radiol 1990; 25: 504-510
12. Kim SH, Park JH, Kim Yl, Kim CW, Han MC. Experimental tissue damage after subcutaneous injection of water soluble contrast media. Invest Radiol 1990; 25: 678-685
13. Mcalister WH, Kissane JM. Comparison of soft tissue effects of conventional ionic, low osmolar ionic and nonionic iodine contaming contrast material in experimental animals. Pediatr Radiol 1990; 20: 170-174
14. Elam EA, Dorr RT, Lagel KE, Pond GD. Cutaneous ulceration due to contrast extravasation: experimental assessment of injury and potential antidotes. Invest Radiol 1991; 26: 13-16
15. Scarim SK. Treatment of doxorubicin extravasations: DICP. Ann Pharmacother 1989; 23: 386-387
16. Scuderi N, Onesti MG. Antitumor agents: extravasation, management, and surgical treatment. Ann Plast Surg 1994; 32: 39-44
17. Mcalister WH, Palmer K. The histologic effects of four commonly used media for excretory urography and an attempt to modify the responses. Radiology 1971; 99: 511-516
18. Few BJ. Hyaluronidase for treating intravenous extravasations. Am J Matern Child Nurs 1987; 12: 87
19. Thomsen HS, Bush WH Jr. Adverse effects of contrast media. Incidence, prevention and management. Drug Safety 1998; 19: 313-324
20. Chrzanowski R. The contrast media used for myelography. Eur Neurol 1982; 21: 194-197
21. Lamb J, Mcallister V, Nelson M, Bartlett R, Smith I, and Deopugari CE. A prospective comparison of iotrolan, iohexol and iopamidol for lumbar myelography. Acta Radiol Suppl 1986; 369: 524-527